Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
The Scientist
Most Recent
A lot changes in a child’s body over the course of development, and not all changes occur linearly: gene expression can fluctuate, and organs can perform different functions on the way to their final purpose in the body. Here are some of the key deve
The Pediatric Research Equity Act (PREA) of 2003 requires that companies developing new drugs that could be used to treat a condition in children perform clinical trials in kids before winning FDA approval. The Best Pharmaceuticals for Children Act (
When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.
UPenn has filed suit against the president of the Memorial Sloan-Kettering Cancer Center for failing to share intellectual property he developed while at the university.
The world’s first programmable drug-delivery chip passes the test, accurately and safely delivering an osteoporosis drug.
The researcher who helped develop an Alzheimer's treatment now in clinical trials warns that the compound may actually impair memory.
The federal agency finally breaks out some information on what it might take to get generic biological drugs approved.
Normal pancreatic function depends on the precise flow of calcium within and into the acinar cells of the organ. When food is eaten, low concentrations of the pancreas-stimulating hormone cholecystokinin or of the neurotransmitter acetylcholine cause
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
